Status:
COMPLETED
Assessment of Subarachnoid Anesthesia With Low Dose of Pethidine and Combination of Ropivacaine With Fentanyl for Urologic Surgical Operations.
Lead Sponsor:
Saint Savvas Anticancer Hospital
Conditions:
Low Dose of Pethidine for Subarachnoid Anesthesia
Eligibility:
All Genders
55+ years
Phase:
PHASE2
PHASE3
Brief Summary
The aim of this study is to assess the efficacy of subarachnoid anesthesia with low dose of pethidine (0.4mgkg-1) compared to administration of ropivacaine and fentanyl which is nowadays the common pr...
Eligibility Criteria
Inclusion
- All patients about to be subjected to Transurethral resection of the prostate (TURP) and Transurethral resection of urinary bladder tumors (TUR)
- Signed informed consent
Exclusion
- When subarachnoid block is contraindicated
- Patient's denial in performing subarachnoid anesthesia
- Failure of subarachnoid block (L1 dermatome in 30 minutes after intrathecal drug administration)
- Mental illness or drug abuse
- Estimated time of operation \>90 minutes
Key Trial Info
Start Date :
August 16 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT03260283
Start Date
August 16 2017
End Date
December 31 2019
Last Update
March 31 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Anticancer Hospital of Athens "Saint Savvas"
Athens, Greece